Delivery Order SPE2DB22D3301-SPE2DB23FZ3VY
Award Date 8/23/23
Potential Completion Date 8/24/23
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,443.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 162 milligram/0.9 milliliter syringes of Actemra. Actemra is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The place of performance for the delivery order is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is brief, spanning just one day from September 19, 2023 through...
- The Defense Logistics Agency awarded a $11,363 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 4561401397 units of the specified medication. Performance will take place in Conshohocken, Pennsylvania over a three-day period from July 3 to July 5, 2023. As the DLA supports military treatment...
- The Defense Logistics Agency awarded a $5,532 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. The single delivery order is for pharmaceutical products to support Department of Defense health programs and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by August 28, 2023. No set aside designation or subcontractors were identified for this small purchase to meet short-term DLA requirements for an...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $15,169.53 to Amerisourcebergen Drug Corporation for the provision of 4561327164 units of Actemra 162 mg/0.9 ml syringes. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from June 23, 2023 through June 26, 2023. No subcontractors or set aside designations were identified. This delivery order was...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $8,096.58 to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. Performance will take place in Conshohocken, Pennsylvania over a period spanning July 25, 2023 through July 26, 2023. The delivery order was issued against an unspecified multiple award contract vehicle held by Amerisourcebergen to supply pharmaceutical products and services in support of the...
- The Defense Logistics Agency Troop Support Medical awarded a $5,198.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 mg/0.9 ml syringes of Actemra. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply the prescription medication Actemra, used to treat rheumatoid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $11,411.43 under a firm fixed-price contract. The delivery order is non-set-aside and carries an ultimate completion date of September 4, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,877.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a $1,299.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561290158 ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is brief, spanning from June 20, 2023 to June 21, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any particular...
- The Defense Logistics Agency awarded a $3,792.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ACTEMRA 200 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 10 ML vials of ACTEMRA, a medication used to treat rheumatoid arthritis, from its facility in Conshohocken, Pennsylvania. The single day order period is July 11 to July 12, 2023. No subcontractors or set aside designations were specified. This order was placed under an existing DLA pharmaceutical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ3VYDelivery Order
The Defense Logistics Agency awarded a $11,519.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligrams per 0.9 milliliter syringes of Actemra. Actemra is a brand name biologic medication used to treat conditions such as rheumatoid arthritis. The place of performance for this contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 23, 2023 through August 24, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA vehicle in support of the agency's mission to provide medical supplies and pharmaceuticals to components of the U.S. Department of Defense.
Generated 12/19/23, 12:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/23/23 |